Exelon Co. (NASDAQ:EXC) Shares Bought by Callan Capital LLC

Callan Capital LLC raised its position in Exelon Co. (NASDAQ:EXC) by 110.4% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 12,099 shares of the company’s stock after acquiring an additional 6,349 shares during the quarter. Callan Capital LLC’s holdings in Exelon were worth $455,000 as of its most recent filing with the SEC.

Other institutional investors also recently bought and sold shares of the company. JPMorgan Chase & Co. grew its stake in shares of Exelon by 109.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 5,884,282 shares of the company’s stock worth $238,608,000 after purchasing an additional 3,068,309 shares during the period. State Street Corp grew its stake in shares of Exelon by 3.7% during the 3rd quarter. State Street Corp now owns 60,169,219 shares of the company’s stock worth $2,439,862,000 after purchasing an additional 2,156,259 shares during the period. Nordea Investment Management AB grew its stake in shares of Exelon by 418.1% during the 4th quarter. Nordea Investment Management AB now owns 2,501,392 shares of the company’s stock worth $94,152,000 after purchasing an additional 2,018,604 shares during the period. FMR LLC grew its stake in shares of Exelon by 18.7% during the 3rd quarter. FMR LLC now owns 11,782,549 shares of the company’s stock worth $477,782,000 after purchasing an additional 1,858,502 shares during the period. Finally, Assenagon Asset Management S.A. grew its stake in shares of Exelon by 212.2% during the 4th quarter. Assenagon Asset Management S.A. now owns 1,903,482 shares of the company’s stock worth $71,647,000 after purchasing an additional 1,293,753 shares during the period. 80.92% of the stock is owned by institutional investors and hedge funds.

Exelon Price Performance

NASDAQ:EXC opened at $43.39 on Friday. The firm has a market cap of $43.62 billion, a price-to-earnings ratio of 17.71, a price-to-earnings-growth ratio of 2.86 and a beta of 0.56. The company has a current ratio of 0.87, a quick ratio of 0.78 and a debt-to-equity ratio of 1.61. The company’s 50-day moving average is $39.41 and its two-hundred day moving average is $39.10. Exelon Co. has a 12-month low of $34.01 and a 12-month high of $43.69.

Exelon (NASDAQ:EXC) last released its earnings results on Wednesday, February 12th. The company reported $0.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.59 by $0.05. Exelon had a net margin of 10.68% and a return on equity of 9.52%. During the same period last year, the business posted $0.60 EPS. Research analysts expect that Exelon Co. will post 2.64 EPS for the current year.

Exelon Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Monday, February 24th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 3.69%. This is a positive change from Exelon’s previous quarterly dividend of $0.38. The ex-dividend date is Monday, February 24th. Exelon’s dividend payout ratio is 62.04%.

Insider Buying and Selling at Exelon

In related news, EVP Colette D. Honorable sold 1,463 shares of the firm’s stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $40.57, for a total value of $59,353.91. Following the sale, the executive vice president now directly owns 2,271 shares of the company’s stock, valued at approximately $92,134.47. This trade represents a 39.18 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.10% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on EXC shares. Guggenheim raised shares of Exelon from a “neutral” rating to a “buy” rating in a research note on Thursday, January 23rd. Scotiabank upped their price target on shares of Exelon from $42.00 to $44.00 and gave the stock a “sector perform” rating in a research note on Thursday, February 13th. Morgan Stanley decreased their price objective on shares of Exelon from $46.00 to $44.00 and set an “equal weight” rating on the stock in a research report on Friday, November 22nd. Barclays decreased their price objective on shares of Exelon from $44.00 to $42.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 22nd. Finally, BMO Capital Markets reiterated an “outperform” rating on shares of Exelon in a research report on Tuesday, February 4th. Five research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $43.38.

Exelon Company Profile

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.